Synthesis and Bioactivity Studies of Benzimidazole-Chalcone Hybrids

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Chalcones, characterized by an α,β-unsaturated carbonyl group, possess broad pharmacological properties.
• Benzimidazole-chalcone derivatives are recognized as significant bioactive compounds with diverse applications.
• There is a growing interest in synthesizing aromatic N-heterocyclic α,β-unsaturated hybrids incorporating benzimidazole-chalcones for therapeutic evaluation.

Purpose of the Study:

• To review the synthetic methodologies for recently developed benzimidazole-chalcone compounds.
• To summarize the biological applications of these synthesized benzimidazole-chalcone derivatives.
• To highlight the potential of benzimidazole-chalcone hybrids as therapeutic agents.

Main Methods:

• Review of synthetic approaches for benzimidazole-chalcone derivatives.
• Compilation of biological activity data from various studies.
• Inclusion of in silico studies on hybridized benzimidazole-chalcones.

Main Results:

• Benzimidazole-chalcones exhibit a wide spectrum of biological activities.
• Evaluated activities include cytotoxicity against cancer cells, antibacterial, antifungal, antileishmanial, antimalarial, antiviral, and antidiabetic effects.
• In silico analyses further support the potential of these compounds.

Conclusions:

• Benzimidazole-chalcone derivatives represent a significant class of bioactive molecules.
• These compounds demonstrate considerable potential for development into effective therapeutic agents.
• The review underscores the importance of benzimidazole-chalcone scaffolds in drug discovery.